PNC Financial Services Group
CBMG

PNC Financial Services Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

PNC Financial Services Group’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,600
Closed -$472K – 4743
2015
Q2 		$472K Buy
+12,600
New +$406K ﹤0.01% 1661

Other funds holding CBMG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

PNC Financial Services Group's CBMG Position: Q3 2015 in Review

PNC Financial Services Group sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q3 2015, closing a stake of 12,600 shares — an estimated $472K sold.

PNC Financial Services Group first reported a position in CBMG in Q2 2015 and held it in 1 quarter. The position peaked at $472K in Q2 2015. 38 funds tracked by Wall St. Rank hold CBMG as of Q3 2015.

  • PNC Financial Services Group reported no remaining Cellular Biomedicine Group, Inc. position as of Q3 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 12,600 Cellular Biomedicine Group, Inc. shares in Q3 2015, an estimated $472K.
  • PNC Financial Services Group first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 1 quarter.
  • PNC Financial Services Group's Cellular Biomedicine Group, Inc. position peaked at $472K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q3 2015.

Based on PNC Financial Services Group's 13F filing for Q3 2015, filed 6 Nov 2015.